REDWOOD CITY, Calif.--(BUSINESS WIRE)--Late-breaking results presented today confirm that incorporating the HeartFlow ® FFRct Analysis into a coronary computed tomography angiogram (CTA)-led ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced new data which indicate that the information provided by the HeartFlow FFRct ...
MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...
Advanced innovations leverage HeartFlow’s core AI technology and are critical additions to HeartFlow’s product portfolio for delivering complete cardiac care REDWOOD CITY, Calif., Dec. 13, 2021 (GLOBE ...
MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by ...
(Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced late-breaking data from the FISH&CHIPS Study presented at the American Heart Association (AHA ...
When doctors need to confirm a coronary artery blockage, they usually recommend a cardiac catheterization. But the procedure, which threads a narrow tube to the heart through the groin, neck or arm, ...